TechThrive Ventures Newsletter

Good afternoon LPs, founders, friends, and everyone,
This one has been a long time coming.

In my early twenties, the plan was pretty simple: Build. Make money. Figure things out. Take a few risks without knowing exactly where they'd lead.

Things I definitely did not have on my life bingo card:

☑ Starting over from zero at the peak of my career
☑ Building a global ecosystem
☑ Writing a book
☑ Launching a venture fund

Yet here we are. 😀 somewhere between starting over, figuring things out, and saying yes to difficult things while saying no to obvious paths. I found myself building toward TechThrive Ventures.

Now that the news is public, I want to share the story behind it. TechThrive didn’t start with a fund thesis. It started with years of building, operating, and working alongside founders and a decision to rebuild from the ground up in the categories I believed in most.

THE MARKET MOMENT

For the last decade, venture capital has largely concentrated around the same patterns. Software eating the world. Marketplaces scaling through efficiency. AI accelerating productivity.But one of the largest platform shifts of the next decade is happening somewhere else entirely.

Human health.
Not healthcare as we have traditionally known it institutional, reactive, and system-driven but health as a consumer category. The lines between healthcare, wellness, longevity, identity, prevention, and everyday consumer behavior are collapsing into one of the largest economic transformations of our time. And yet, many of the founders building in these categories still remain structurally underserved by early-stage capital.

That disconnect is the white space TechThrive Ventures was built for.

WHY I STARTED THE FUND

Over the past eight years, I have built companies, scaled consumer products, managed large teams, and worked across startups and scale-ups navigating growth, partnerships, expansion, and capital formation across India, the UK, Europe, and the U.S. Those experiences shaped how I think about markets and company building at a level that no amount of deal tracking can replicate.

The last year gave me the space to rebuild, reflect, and become clear on the kind of work I want to do and the kind of people I want to build alongside. This next chapter feels aligned. Smaller circle. Bigger impact.

THE BUILD : HOW CONVICTION IS EARNED, NOT ASSEMBLED

If you've followed my journey, you've seen some of this happen in real time. When I started FemTech India in 2022, I didn't know a single VC or founder in the ecosystem. I had stepped away from my family business in the (consumer space), where I led a team of 80 at the peak of that chapter to start again from zero. That experience taught me how to build under pressure, scale across markets, and operate in high-investment, high-risk environments. It was not venture but it was real execution. And it became the foundation for everything that followed.

What started with two interns turned into three years of building: a global ecosystem of 450+ companies, founders, investors, and operators; the first-ever FemTech industry book supported by UNFPA; a podcast reaching 90+ countries; and direct working relationships with hundreds of founders navigating one of the hardest categories to scale.

One thing became clear through all of it: strong companies don't fail for lack of innovation. They fail when early capital, distribution pathways, and global networks are missing. The gap is not just financial. It is infrastructural. That is why I decided to build TechThrive Ventures.

THE TIMELINE:

THE THESIS

Four forces are converging right now and most venture capital is still looking the other way. Aging demographics. Post-pandemic health ownership. The collapse of trust in legacy CPG brands. And a new data layer wearables, genomics, continuous monitoring making personalized health actionable at consumer scale for the first time. This is not a cyclical trend. It is an infrastructure shift in how humans understand, manage, and optimize their own biology.

TechThrive is built around one core belief: The largest opportunities of the next decade will come from sectors that traditional venture has historically underestimated.

We invest at the intersection of underserved consumer demand, long-term behavioral shifts, and cultural change across five categories:

THE ADVANTAGE WE EARNED ⭐

Over the years, many of you reached out to say the work mattered. That it opened doors. It changed how you thought about this space. Thank you. This space is deeply personal to me, and I feel a strong responsibility in how we help shape it and an even stronger conviction in where it is going.

TechThrive Ventures is the next chapter and for the first time, we are creating a path for others to invest alongside us. To own a piece of the industry we helped build.

Co - invest with us → Reserve your spot

Don’t ask me for VC advice. I survived on black coffee and Coffee on repeat ☕

If you’ve read this far, you deserve a cup. Enjoy 😊

In Q1 2026, the non-traded BDC market hit $20.8B in redemption requests — most investors received roughly half of what they asked for. Moody's revised the U.S. BDC sector outlook to Negative. Investors who thought they owned liquid private credit found out their fund manager decided whether they could get out.

On Percent's marketplace that same quarter: new issuances, scheduled payments, and a 0.44% lifetime net loss rate on asset-based deals that's held since inception.†

The difference is structural. BDCs often own concentrated corporate loans with quarterly redemption windows that close at the manager's discretion. Percent finances specialty lenders against pools of performing receivables — diversified, overcollateralized, short duration.

Track record through 3/31/26:†

See what private credit built for individual investors looks like.

^{Alternative investments are speculative. No assurance can be given that investors will receive a return of their capital. Secondary market transactions are subject to availability and issuer approval; liquidity is not guaranteed. †Past performance is not indicative of future results. Terms apply.}